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Abstract

Introduction

Reduced citrate in urine and increased fasting excretion of calcium are abnormalities frequently reported in
stone forming (SF) patients. Increased dietary acid (or
reduced alkali) introduction or absorption may be a potential cause of both these pathological findings. To test
this hypothesis, we studied 64 SF patients {32 with fasting hypercalciuria (FH) and 32 without FH (NFH)}.
After a basal evaluation for nephrolithiasis, while on a
500 mg calcium diet, they were evaluated for: (l) daily
intestinal alkali absorption (IAA), by urinary electrolyte
excretion; (2) basal concentrations of PTH, calcitonin
(CT) and l,25(OH)2-VitD; (3) oral calcium load for
evaluation of changes in calcium and hydroxyproline urinary excretions; (4) intestinal calcium absorption (18
patients), with double curve analysis (stable Sr as tracer); and (S) changes in citrate excretion after an alkali
load (50 mEq of a mixture of calcium gluconate, lactate
and carbonate) in 10 patients.
The results demonstrated: (1) FH stone formers had
reduced citrate excretion and lower mean IAA levels
than NFH stone formers; (2) FH stone formers also had
higher bone resorption levels with lower PTH and higher
CT levels; (3) IAA levels were related to both citrate excretion and bone turnover indices; and (4) the increases
in citrate excretion after oral alkali load were strictly
related to basal IAA values (index of alkali absorption
and/or generation after oral load), demonstrating that a
different absorptive capacity of alkali rather than a
different dietary content may underlie these metabolic
abnormalities.

Reduced urinary citrate excretion is a common trait
among patients who form stones [9, 21, 22]. Acidosis
is the main factor in causing hypocitraturia encountered
in distal renal tubular acidosis [16], chronic diarrheal
states [19], and thiazide-induced hypokalemia [20].
However, in most hypocitraturic stone formers (SF), no
exact cause can be identified. Increased dietary intake
of protein, mainly composed of sulphur-containing
amino acids, resulting in acid load, has been suggested
as a putative factor in "idiopathic" hypocitraturia [3].
Another possible explanation is that low alkali intake or
absorption might be the causative factor. In 1987,
Cowley et al. [6] found a reduced citraturic response after an oral citrate load in SF. Since Oh [ 17] introduced
a simple and reliable method for the calculation of net
gastrointestinal alkali absorption (IAA), it has been possible to directly relate citrate excretion with IAA. Indeed, Pak [18] demonstrated that IAA, after an oral citrate load, was reduced in some SF, suggesting reduced
intestinal absorption. The first aim of the present study
was to confirm or otherwise test this hypothesis, by directly measuring citrate excretion after an oral alkali
load other than citrate.
It has also been suggested that increased levels of
bone turnover (BT), independen't of PTH secretion,
might play a causative role in fasting hypercalciuria
(FH) of SF [2, 13, 14], especially in conditions of relatively low calcium intake [12]. In this pathophysiologic
set, a relative hypoparathyroidismhas also been reported
[8]. Notwithstanding a well known role of calcitonin
(CT) in controlling BT rate [7], after the initial finding
by Ivey et al. [10] of increased CT levels in hypercalciuria, little attention has as yet been paid to this hormone
in FH SF. The second aim of our study has been to further investigate the CT role, if any, in FH of SF.
Furthermore, it has also been demonstrated that increased dietary acid load is able to induce increased calcium excretion in urine together with increased bone resorption [l, 11]. The final aim of the present investigation was to assess whether the alkali composition of the

Key Words: Intestinal alkali absorption, citrate, bone
resorption, hydroxyproline, fasting hypercalciuria, calcitonin, parathyroid hormone, urolithiasis, intestinal
calcium absorption, vitamin D.
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Table 1. Main clinical data of the two groups of patients (mean

±

standard deviation, sd; ns

= not significant).

N

CrCl
(ml/min)

Age
(years)

BMI

Sex
(F/M)

Activity (no. Stones/
last 2 years)

NFH

32

106 ± 4.0

39.9 ± 10.7

25.0 ± 0.18

14/18

3.1 ± 4.0

FH

32

104 ± 3.8

44.3 ± 12.7

24.6 ± 0.18

15/17

2.8 ± 1.0

ns

ns

ns

ns

ns

p

Table 2. Daily urine parameters and calculated IAA
values in FH and NFH patients (mean ± sd).

urinary Citrate mmol/day
12

NFH
(n 32)

FH
(n 32)

p value

u-Ca mmol/day

4.6 ± 1.8

5.95 ± 2.73

< 0.05

uNa mmol/day

140 ± 68

170 ± 89

ns

uMg mmol/day

4.0 ± 1.5

4.5 ± 2.1

ns

u-Pi mmol/day

26.1 ± 11.3

25.7 ± 11.9

ns

u-Ox mmol/day

360 ± 155

398 ± 202

ns

u-Cit mmol/day

3.68 ± 1.85

2.28 ± 1.37

< 0.05

uUA mmol/day

4.0 ± 4.9

3.7 ± 1.4

IB

uSulf mmol/day

21.1 ± 6.9

21.3 ± 6.7

IB

uUrea mmol/day

328 ± 143

379 ± 136

ns

31.2 ± 19.4

15.3 ± 18.3

< 0.05

IAA mEq/day

• •

8

•

4

0

•
• • ••
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-30
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diet might also play a role in increased bone turnover of
FH.

Patients and Methods
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•
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Figure 1. Correlation between IAA values and urinary
citrate excretion. A significant linear direct correlation
was evident (Cit = 2.65 + 0.018 x IAA; r = 0.382,
p < 0.001).
intestinal alkali absorption (IAA; see below). On the
third day, after 12 hour of complete fast, freshly voided
2-hour urines were analysed for: calcium, phosphate,
hydroxyproline and creatinine. A blood sample was also
obtained for evaluating: calcium, phosphate and the
other electrolytes, acid-base balance, creatinine, intact
PTH, monomeric CT and l,25(OH)2-VitD.
Then an
oral calcium load (OCL) {1 g of calcium ion, given as
a mixture of calcium gluconate, lactate and carbonate
(Calcium Sandoz)} was performed and in the urines collected for the following 4 hours, calcium, phosphate,
hydroxyproline and creatinine were evaluated. A blood
sample was also obtained 2 hours after OCL for the
evaluation of: calcium, bicarbonate, PTH and CT. According to fasting calcium excretion values (Ca/Cr above
or below 0.310 mmol/mmol), the patients were defined
as respectively fasting hypercalciuric (FH) and not
fasting hypercalciuric (NFH) SF; by chance, 32 of them
were FH and 32 NFH.
In addition, in 18 (9 FH and 9 NFH) of these
patients, intestinal calcium absorption (ICaA) was
measured by a double curve analysis, utilizing stable

Among the patients evaluated for active urolithiasis
in our Nephrology Unit in the last 4 years, we enrolled
64 patients (29 females, 35 males; ages 19-63 years), on
the basis of the presence of hypercalciuria, defined as a
daily urinary calcium excretion > 0.1 mmol/kg bw/day
(bw = body weight), on a free diet and the common
composition of the expelled stones (calcium oxalate).
None of them suffered from primary hyperparathyroidism, overt renal tubular acidosis, or medullary sponge
kidney disease; no drug known to affect calcium metabolism was consumed by any patient, at least in the two
months preceding the study. At least 2 months had
elapsed from the last expelled stone or urological
intervention.
For all 64 patients, after 15 days on an ambulatory
diet, with a moderately restricted calcium content (about
500 mg), daily urines were collected on two consecutive
days for the assessment of: calcium, sodium, potassium,
magnesium, chloride, phosphate, sulphate, citrate, oxalate, uric acid, urea, creatinine and the calculation of
532
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Figure 2. Correlations between the increase of citrate excretion after OCL and both daily urinary citrate (a) and IAA
(b). A significant positive linear relationship was evident in both cases (daily Cit = 0.037 + 0.033 x dCit; r = 0. 717,
p < 0.01; IAA = 0.028 + 0.003 x dCit; r = 0.742, p < 0.01).
strontium as tracer, according to a method already described [15): briefly, 2.5 mmol and 1.25 mmol of stable
strontium were given, on two separate days, respectively
by mouth and intravenously in bolus; then multiple
blood samples were obtained at 0, 5, 10, 15, 30, 60,
120, 180, 240, 360, 480, 600 minutes for the measurement of Sr [4] and the calculation of true intestinal absorption was obtained by integrating the two curves [15].
Furthermore, in 10 of these patients, urinary citrate
and intestinal alkali absorption were evaluated before
and after OCL, which also represents an alkali load of
50 mEq.
Intestinal alkali absorption (IAA) in the daily urine
of all 64 patients and in urine collected before and after
OCL, in 10 patients, were calculated according to the
formula suggested by Oh [17):
IAA = (Na

Strontium in serum was measured by atomic absorption spectrophotometry [4].
Urinary oxalate and citrate were measured by column gaschromatography (Hewlett-Packard 5890 II;
Supelco SPB-5), in urine collected under 6N HCI.
Hydroxyproline in urine was determined by liquid
chromatography (Beckman System Gold), after acid
hydrolysis.
PTH was measured by intact-PTH immunoradiometric assay (IRMA, NICHOLS Institute Diagnostic,
San Juan Capistrano, CA, USA), utilizing two different
policlonal antibodies, purified by affinity chromatography, specific for 39-84 and 1-34 regions. The intra-assay coefficient of variation was 2.4% and the inter-assay
coefficient 5. 6 %.
Calcitonin was analyzed by radio-immunoassay with
double antibodies in liquid phase (NICHOLS). This assay has been proven to be specific for monomeric CT
(the active hormone) [5], with an intra-assay coefficient
of variation of 3. 3 %, and an inter-assay coefficient of
5.5%.
For l,25(OH)2-vitamin D determination, a 10 ml
blood sample was collected with heparin, immediately
centrifuged at 4°C and stored at -20°C, until the assay
was performed (within 20 days). After acetonitrile extraction, in the presence of tritiated calcitriol (as an indicator of extraction efficiency), plasma sample was submitted to a "phase switching" procedure, using a single
C-18OH cartridge (BondElut) for subsequent separation

+ K + Ca + Mg) - (Cl + 1.8 iP)

where Na, K, Ca, Mg, and Cl are expressed as mEq
and iP (inorganic phosphate) as mmol, excreted in daily
unnes.
Tubular threshold of phosphate (TTPi) was calculated by urinary excretion of phosphate and creatinine in
fasting urine, according to Walton and Bijvoet [23].
Electrolytes, creatinine, urea and uric acid in serum
and urine were measured by standard methodology
(autoanalyzer, absorption spectrophotometry, flame
photometry).
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Table 3. Calciotropic hormones, calcium-phosphate parameters, ICaA, and bone resorption levels in FH and NFH
patients, in basal conditions (mean ± sd). The ICaA values were measured in 18 patients only (see text).
PTH
pg/ml

CT
pg/ml

1,25
pg/ml

OHP/Cr
mmol/mol

ICaA
%

ITPi
mmol/1

iCa
mmol/1

27.6 ± 10

12.9 ± 12

35.6 ± 11

13.5 ± 4.6

40.1 ± 14

1.0 ± 0.3

1.29 ± 0.02

n=

32

32

32

32

9

32

32

FH

20.7 ± 11

28.8 ± 24

38.8 ± 14

18.1 ± 11.1

46.3 ± 8

1.0 ± 0.2

1.31 ± 0.03

n=

32

32

32

32

9

32

32

p

< 0.01

p < 0.05

ns

p < 0.01

ns

ns

ns

NFH

Table 4. Main results of OCL in FH and NFH patients (mean

±

sd).

dCa/Cr
mmol/rnmol

dCa
mmol/1

dOHP/Cr
rnmol/mmol

dPTH
%

dCT

NFH (n = 32)

0.185 ± 0.17

0.12 ± 0.10

-4.0 ± 7.7

-44.9 ± 60.4

26.0 ± 45.4

FH (n = 32)

0.169 ± 0.27

0.47 ± 0.47

-4.9 ± 8.5

-34.3 ± 48.9

9.9 ± 34.5

ns

ns

ns

ns

ns

p

of25-(OH)D, 24,25-(OH)2D and 1,25-(OH)2D with isopropanolol-hexane; then the final product was dried by
nitrogen stream and measured by radioreceptorial
method (RRA, NICHOLS). Each sample was analyzed
in duplicate. The recovery for this metabolite was
between 60 and 80 % and each sample was corrected for
its own recovery.
The intra-assay coefficient of
variation was 10.0% and the inter-assay coefficient of
variation was 14.0%.
Statistics were calculated by Anova, paired T test
and linear regression analysis utilizing a BMDP computer statistical package on an Olivetti M-300-10 PC.

%

The main clinical data of the 10 patients (6 males,
4 females; 44.9 ± 8.7 years in age) in whom citrate and
IAA were measured before and after OCL were as follows: creatinine clearance 103.7 ± 18.2 ml/min; BMI
24.8 ± 3.5; and activity (number of stones / last two
years) = 4.9 ± 5.5. Both urinary citrate and IAA significantly increased after OCL (Cit/Cr: 3.91 ± 0.22
versus 2.37 ± 1.47 rnmol/mmol; p < 0.001; IAA: 2.6
± 2.2 vs 0.9 ± 1.3 mEq/hr). The increase of citrate
excretion was significantly and positively related to the
daily levels of both urinary citrate (Fig. 2a) and IAA
(Fig. 2b). On the other hand, no correlation was found
between the increase of IAA after OCL and basal IAA
values.
The basal levels of calciotropic hormones and related data, ICaA, and BT are shown in Table 3. FH SF
patients had higher bone resorption (as measured by
OHP/Cr), with lower PTH and higher CT levels than
NFH SF. No differences were evident in VitD status,
ICaA or calcium-phosphate parameters. The concentrations of CT were significantly and directly related to
daily urinary calcium excretion (Fig. 3a) and inversely
to citrate excretion (Fig. 3b). Furthermore, the levels of
CT and hydroxyproline excretion were inversely related
to IAA basal values (Fig. 4).
The main results of OCL in the two groups of patients are shown in Table 4. No significant difference
was evident between the two groups of patients, however
CT changes after OCL tended to be higher in NFH, and

Results
The main clinical data of the FH and NFH patients
are shown in Table 1. No differences were indicated
between the two groups as regards age. sex distribution,
renal function (evaluated by creatinine clearance), stone
activity and body mass index (BMI).
Table 2 summarizes the main 24-hour urine parameters and the calculated values of IAA in the 2 groups.
FH patients had significant higher calcium, lower citrate
urinary values and significant lower IAA levels, with no
significant difference as regards the other parameters.
Furthermore, the IAA values were significantly and positively correlated with citrate urinary excretion (Fig. 1).
Citrate excretion values did not appear significantly correlated with either urea or sulfate daily urinary excretion.
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Figure 3. Correlations between basal CT serum levels and daily urinary excretions of calcium (a) and citrate (b). A
direct linear correlation was evident between CT and daily calciuria (uCa = 4.9 + 0.022 x CT; r = 0.238, p < 0.05)
and an indirect hyperbolic correlation with urinary citrate (lnCit = 1.66 - 0.26 x lnCT; r = 0.443, p < 0.001).

deed, Cowley et al. [6], utilizing a citrate load, found
reduced citrate excretion in stone formers and, more recently, Pak [18) indirectly confirmed these results demonstrating increased IAA after oral citrate load. However, in the first case [6], the increase in citrate excretion was obtained during the specific load of the same
alkali (i.e., citrate) and this finding is not necessarily
indicative of citraturic response after an aspecific alkali
load, and in the second study [18], the response to alkali
load was assessed as the increase in IAA, evaluated with
Oh method, which is not the recommended method to
measure alkali absorption when an acid-base perturbation
is going on, as during an alkali load [17]. We tested the
increase of citrate excretion and of IAA after an alkali
load of 50 mEq, represented by calcium gluconate, lactate and carbonate, and found that the increase of citrate
excretion after OCL was direct correlated with basal
IAA. These finding, in our opinion, support the hypothesis that IAA is mainly dependent on the intestinal transport capacity of the intestine, after an oral alkali load,
and not on the alkali content of the diet. The lack of
correlation between basal IAA values and changes in
IAA after OCL confirm that the measurement of IAA by
Ob's method during an ongoing perturbation of acid-base
balance is not reliable, as stressed by Oh himself [ 17].

the percentage CT increase was inversely correlated with
basal levels of CT (Fig. 5).
Discussion
An overt lsause of reduced citrate excretion, which
frequently occurs in the urines of SF patients, is often
lacking. Considering that both intra and extracellular
acidosis is the common factor in all the conditions
known to be accompanied by hypocitraturia [16, 19,
20), it is conceivable that increased acid or reduced alkali intake in the diet might be the causal factor of the "idiopathic" form ofhypocitraturia. The method suggested
by Oh [17] for calculating IAA, by simply measuring
electrolyte excretion in daily urines, has led to the possibility of testing the above hypothesis. Indeed, the data
from Pak [18] clearly suggest that IAA affect the levels
of urinary citrate, and our results confirm these data
(Fig. 1). However, these results may be a consequence
of either reduced alkali content in the diet or reduced
alkali transport efficiency in the intestine. In our patients, no correlation was found between urinary citrate
and urea and sulphate daily output (indices of protein
and acid content of the diet), suggesting that the alkali
food content is not the main cause in this respect. In-
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Figure 4. Correlations between IAA levels and fasting hydroxyproline urinary excretion (a) and basal CT serum
concentrations (b). An inverse correlation was evident in both cases (OHP = 21. 7 - 0.07 x IAA; r = 0.345, p <
0.01; CT = 19.4 - 0.15 x IAA; r = 0.400, p < 0.01).

Evidence has been provided that fasting hypercalciuria is often accompanied by increased bone resorption
indices and reduced PTH levels [2, 12, 13, 14]. Little
attention has as yet been paid to the CT role in this
pathophysiological condition, after a previous finding of
increased CT levels inhypercalciuria by Ivey et al. [10].
Indeed, our data confirm higher values of CT in patients
with FH, and its values were significantly related to both
calcium (positively) and citrate (negatively) urinary excretions (Fig. 3). A possible explanation for all these
findings may be an increased dietary calcium absorption,
possibly due to increased VitD bioavailabiiity, which
might cause increased calcium excretion, stimulated CT
and suppressed PTH and perhaps by a concomitant increased content of protein and acid load in the diet, reduced citrate excretion and increased bone resorption.
This hypothesis is well supported by Hess's data [8]
which demonstrated that the relative hypoparathyroidism
of hypercalciuric stone formers might be explained by
increased levels of VitD and secondary increased calcium absorption. However, in our patients, the levels of
VitD were completely overlapping in the two groups of
SF, with or without fasting hypercalciuria. Furthermore, there were no differences in ICaA in the 18 pa-

tients for whom it was measured, nor in the increase of
calcium excretion after OCL between FH and NFH
stone formers. The apparent discrepancies between our
results and Hess's [8] are at least in part due to a different calcium intake in the two studies (reduced in our,
free in Hess's) and a different method of classification
(our patients were divided on the basis of the presence
or otherwise of FH, Hess's patients on the presence or
otherwise of daily hypercalciuria). An alternative explanation might be that the different alkali absorption by the
intestine might play a role.
Indeed, another interesting finding of our study was
that both citrate and IAA were significantly lower in FH
patients. Furthermore, IAA values were inversely correlated to both hydroxyproline and CT levels. Taken together all the results might suggest that in FH, reduced
IAA might induce not only a reduction in citrate excretion, as suggested by Pak [ 18], but also an increased
bone resorption, secondary to the well known effect of
acid-base balance perturbations on bone resorptive rate
[ 11]. The increased bone resorption in tum might sustain increased calcium excretion in fasting urines and a
resetting of parathyroid glands and thyroid C-cells with
a consequent compensatory reduced PTH and increased
536
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441-443.
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Urology 21: 8-14.
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G-I absorption of alkali. Kidney Int 36: 915-917.
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Figure 5. Correlation between the percentage changes
inCT after OCL and its basal values. An inverse linear
relationship was evident (dCT% = 29.0 - 0.37 x CT; r
= 0.277, p < 0.02).

CT secretion. This resetting of secretion is, at least in
part, supported by the finding of the reduction of CT secretory response to OCL proportional to the basal CT
levels: i.e., the higher the basal secretory rate the lower
the stimulated secretory response. However, to further
validate this last hypothesis, studies specifically directed
to measuring the CT secretion rate in these kinds of
patients are needed.
Conclusions

Citrate excretion is mainly controlled by intestinal
alkali absorptive capacity. Stone formers with fasting
hypercalciuria, together with higher BT and relative
hypoparathyroidism, present lower urinary citrate,
higher urinary calcium and higher CT levels; reduced
IAA levels might be the link for all these findings.
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and on the other hand, an increase in bone reabsorption
due to the well-known direct and indirect effect of acidbase balance variations on bone metabolism. As regards
the possible explanation for the increase in CT in conditions of increased bone turnover, it may be only speculatively supposed that a condition of increased bone resorption may up-regulate the secretion of a hormone
(CT) which has the physiological role of "cooling" that
metabolic process.

A. Trinchieri: The correlation between the increase of
citrate excretion after calcium load and both basal urinary citrate and intestinal alkali absorption is impressive,
but the lack of correlation between the changes in intestinal alkali absorption after calcium load and basal intestinal alkali absorption could be due to the very low number of patients in which urinary citrate was evaluated.
Furthermore, it would be interesting to distinguish the
effect of an alkali load between hypercalciuric and nonhypercalciuric stone formers.
Authors: We are in total agreement that, given the relatively low number of observations (10) on IAA before
and after alkali load, the absence of a correlation may
not necessarily be true, but we have to comment on our
statistical data as they stand.

Discussion with Reviewers
D.M. Wilson: According to the discussion by Oh [17],
the alteration in IAA could be related to an abnormality
in GI absorption but could also reflect cellular changes
or bone buffering. Is it possible that the calculated
change in IAA is a consequence of altered bone buffering or cellular metabolism?
Authors: What you say is true and is affirmed in the
Discussion. In fact, the method of calculation for alkali
absorption suggested by Oh [17] is usable only in the
basal conditions and when it is presumed that there are
no changes in bone and/or cellular buffering capacity.
Indeed, our data show that IAA, measured by that method before and after alkali load (a condition that may be
accompanied by a change in the cellular buffering) does
not correlate with the IAA values measured in basal
conditions.

W.C. de Bruijn: As regards the stone formers (SF),
please give an indication as to which stones were formed
(calcium-oxalate, struvite?) and comment on the homogeneity of this population in this respect.
Authors: As stated in the text, all the SF patients
studied had expelled stones prevalently composed of
calcium oxalate.

W.C. de Bruijn: Various tests are performed with
blood and urine samples from these SF, but can you,
more explicitly, give the number of patients related to
each graph.
Authors: As stated in the text, the total population studied was 64 patients and basal IAA had been measured in
all; the 18 patients who had also had their intestinal calcium absorption measured belonged to the first population; in 10 of these patients citraturia and IAA were also
measured both before and after alkali load. Thus, the
graphs in Figures 1, 3, 4 and 5 show the observations in
the total population (1 observation per patient); graph In
Figure 2 shows the observations in the 10 patients who
had their IAA and citraturia measured before and after
alkali load.

H.-G. Tiselius: The authors state that an increased
IAA, in addition to a reduced excretion of citrate, leads
to hypercalciuria brought about by an increased bone resorption and an increased calcitonin concentration. The
patients in this study, however, did not differ in
1,25-vitamin D levels or in calcium absorption.
It
would be interesting if the authors, in more detail, could
describe how the different findings in these patients can
be explained from a reduced IAA.
Authors: As stated in the text, lower IAA values were
associated with lower citraturia and higher bone turnover
indices. The hypothesis suggested is that a lower availability of alkali from intestine would determine, on one
hand, lower excretion and/or renal production of citrate,

W.C. De Bruijn: In most graphs, a linear relation is
assumed to be present and calculated and the coefficients
given in the legends. But in Figure 3b suddenly a logarithmic relation is presented. What was the basic as538
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sumption to ask the computer to draw these linear relations and why not so in Figure 3b, and why is not in all
cases a non-linear relation is assumed and/or tested.
Once a (linear) relation is acquired, the correspondence
coefficient (r) is indicative for the value one can give to
the observed relation. In most cases shown, this value
is rather low (ranging from 0.238 - 0. 742) whereas a
value around unity is acquired for a perfect correspondence. Please comment on this aspect and discuss the
consequences.
Authors: The significance of the coefficient "r" is that
of defining, as is known, the degree of correlation between two variables, of which one is taken as independent and the other dependent, the correlation being greatest for values of "r" close to unity. Of course, when the
independent variable is the only one (or in any case preponderant), in order to determine the variations in the
dependent variable (e.g., time versus a tracer concentration, the concentration of a chemical substratum versus
the final product of a chemical reaction, etc.) for a correlation to be "good", the value of "r" must really be
near unity. In multi factor biological systems (like those
explored in clinical, physiopathological, epidemiological
studies, etc.), "r" values are obviously much lower
(there being many other factors, known and unknown,
that cannot be considered in every single analysis):
statistical significance tests intervene precisely to prove,
or not, whether the relation existing between the variables examined is significant, weighing it by the number
of observations and the spread of data around the interpolating line.
As regards the type of interpolation, when two variables are put in relation to one other, the function (given
that there is one) that best interpolates the observed
points should always be sought. It is natural that the
linear function is the first to be explored but we always
try the interpolation of at least the most common functions (hyperbolic, parabolic, logarithmic, exponential).
Of course, in the end, the one that provides the highest
"r" value will be chosen, to indicate a better interpolation of the way the relation is going.
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